US Stock MarketDetailed Quotes
CLPT ClearPoint Neuro
- 13.180
- +0.620+4.94%
Close Aug 29 16:00 ET
- 13.380
- +0.200+1.52%
Post 18:43 ET
363.71MMarket Cap-18828P/E (TTM)
13.370High12.560Low161.26KVolume12.560Open12.560Pre Close2.11MTurnover0.64%Turnover RatioLossP/E (Static)27.60MShares13.37052wk High11.32P/B332.64MFloat Cap4.05052wk Low--Dividend TTM25.24MShs Float31.290Historical High--Div YieldTTM6.45%Amplitude2.860Historical Low13.060Avg Price1Lot Size
ClearPoint Neuro Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 47.43%-2.67M | 32.39%-3.84M | 15.14%-13.72M | 61.86%-1.17M | 53.37%-1.8M | -1.89%-5.08M | -33.05%-5.68M | -27.33%-16.17M | 13.71%-3.07M | -16.87%-3.85M |
| Net income from continuing operations | 37.49%-4.41M | 26.08%-4.15M | -34.40%-22.09M | -5.34%-4.62M | -26.95%-4.81M | -63.89%-7.05M | -41.68%-5.61M | -14.05%-16.44M | -5.69%-4.39M | 4.82%-3.79M |
| Depreciation and amortization | 36.58%463K | 74.91%474K | 87.52%1.46M | 177.12%424K | 148.82%423K | 44.26%339K | 23.74%271K | 12.28%777K | -14.53%153K | -7.61%170K |
| Other non cash items | 132.56%14K | 127.27%15K | 69.87%-69K | 113.51%15K | 111.48%14K | -377.78%-43K | -523.08%-55K | -153.88%-229K | -265.67%-111K | -206.09%-122K |
| Change In working capital | 30.36%-172K | 12.69%-1.54M | 91.70%-356K | 749.62%1.11M | 145.06%543K | 86.54%-247K | -27.90%-1.77M | -154.69%-4.29M | 121.62%131K | -331.90%-1.21M |
| -Change in receivables | -49.01%-602K | 559.78%846K | -754.98%-1.8M | -248.12%-1.14M | -489.47%-74K | 65.05%-404K | -218.71%-184K | 67.93%-211K | 305.79%771K | 108.23%19K |
| -Change in inventory | -155.51%-373K | 109.17%53K | 128.18%1.25M | 189.12%983K | 111.03%169K | 174.17%672K | 34.32%-578K | -157.93%-4.42M | -6.88%-1.1M | -305.29%-1.53M |
| -Change in prepaid assets | -15.91%-459K | 492.86%165K | 90.71%-113K | -436.36%-354K | 585.00%679K | 65.20%-396K | -132.81%-42K | -360.61%-1.22M | -119.70%-66K | -186.96%-140K |
| -Change in payables and accrued expense | 144.76%1.66M | 2.92%-931K | -140.79%-649K | 11.31%374K | -228.65%-741K | -50.62%677K | -38.58%-959K | 23.81%1.59M | 352.63%336K | 443.40%576K |
| -Change in other current assets | --0 | ---39K | 466.67%22K | --0 | 4,600.00%47K | ---25K | --0 | 90.91%-6K | 2.63%-37K | -98.46%1K |
| -Change in other current liabilities | -56.46%-230K | -17.12%-171K | -39.56%-755K | -43.26%-202K | -87.05%-260K | -10.53%-147K | -14.06%-146K | -25.23%-541K | -17.50%-141K | -18.80%-139K |
| -Change in other working capital | 73.56%-165K | -1,116.67%-1.46M | 229.51%1.7M | 291.91%1.45M | 7,130.00%723K | -591.34%-624K | 1,957.14%144K | 212.12%515K | 93.23%371K | -91.30%10K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 47.43%-2.67M | 32.39%-3.84M | 15.14%-13.72M | 61.86%-1.17M | 53.37%-1.8M | -1.89%-5.08M | -33.05%-5.68M | -27.33%-16.17M | 13.71%-3.07M | -16.87%-3.85M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 183.36%8.95M | -101.60%-188K | 62.76%-235K | 143.89%9.51M | 25.41%-138K | -6,290.48%-10.74M | 31,010.53%11.75M | -404.80%-631K |
| Net PPE purchase and sale | --0 | --0 | -183.40%-717K | 46.15%-21K | -240.58%-235K | -325.00%-323K | -100.00%-138K | -50.60%-253K | -2.63%-39K | 44.80%-69K |
| Net intangibles purchase and sale | ---- | ---- | 62.60%-334K | 22.33%-167K | --0 | ---- | ---- | ---893K | ---215K | ---562K |
| Net investment purchase and sale | ---- | ---- | 204.28%10M | --0 | --0 | ---- | ---- | ---9.59M | --12M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 183.36%8.95M | -101.60%-188K | 62.76%-235K | 143.89%9.51M | 25.41%-138K | -6,290.48%-10.74M | 31,010.53%11.75M | -404.80%-631K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -32.49%160K | 321,160.00%16.05M | -27.63%296K | -30.18%155K | 72.34%-91K | -53.80%237K | -266.67%-5K | -99.13%409K | 362.50%222K | 27.21%-329K |
| Net common stock issuance | --0 | --16.18M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | -8.28%288K | --21K | -32.08%506K | -13.51%192K | --0 | -38.79%314K | --0 | 8.13%745K | 111.43%222K | -92.22%7K |
| Net other financing activities | -66.23%-128K | -2,920.00%-151K | 37.50%-210K | ---37K | ---91K | ---77K | ---5K | 43.91%-336K | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -32.49%160K | 321,160.00%16.05M | -27.63%296K | -30.18%155K | 72.34%-91K | -53.80%237K | -266.67%-5K | -99.13%409K | 362.50%222K | 27.21%-329K |
| Net cash flow | ||||||||||
| Beginning cash position | 62.23%35.35M | -16.20%23.14M | -48.96%27.62M | 30.09%24.34M | 12.50%26.46M | -56.12%21.79M | -48.96%27.62M | 169.21%54.11M | -67.54%18.71M | -61.76%23.52M |
| Current changes in cash | -153.68%-2.51M | 309.74%12.21M | 83.11%-4.48M | -113.50%-1.2M | 55.90%-2.12M | 117.88%4.67M | -30.82%-5.82M | -177.90%-26.49M | 351.36%8.9M | -24.24%-4.81M |
| End cash Position | 24.11%32.85M | 62.23%35.35M | -16.20%23.14M | -16.20%23.14M | 30.09%24.34M | 12.50%26.46M | -56.12%21.79M | -48.96%27.62M | -48.96%27.62M | -67.54%18.71M |
| Free cash flow | 52.06%-2.67M | 34.00%-3.84M | 14.68%-14.77M | 59.11%-1.36M | 54.70%-2.03M | -10.05%-5.57M | -30.62%-5.82M | -34.57%-17.31M | 7.55%-3.32M | -31.04%-4.48M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
